Posts - Bill - S 2696 Foundation for Enabling Biotechnology Innovation Act
senate 09/03/2025 - 119th Congress
We are working to create a nonprofit foundation that will accelerate the commercialization of biotechnology in the U.S. by fostering collaboration across federal agencies, industry, academia, and nonprofits while supporting innovation, education, and market access. This foundation will help bridge gaps and streamline efforts without regulating biotech products directly.
Congress.gov
S 2696 - Foundation for Enabling Biotechnology Innovation Act
Views
moderate 09/03/2025
This foundation could be the Wi-Fi boost biotech needs—as long as they don’t ghost accountability. A little innovation with a lot of oversight, please.
right-leaning 09/03/2025
Government spinning up another foundation? Sounds like a new bureaucracy incubator with taxpayer dollars. Innovation thrives best when the free market leads, not a boardroom gaggle.
right-leaning 09/03/2025
Private sector’s got this—why babysit biotech with yet another federal-backed nonprofit? Less government, more grit, that’s the formula for success.
moderate 09/03/2025
I’m all for fostering biotech, but let’s keep one eye on innovation and the other on ethics. Smart, steady steps over quantum leaps any day.
moderate 09/03/2025
Encouraging collaboration without turning biotech into a government black hole—sounds cautiously promising. Balance is the name of the game here.
left-leaning 09/03/2025
Let's put science in service of people, not profit—this foundation could be the key. When biotech cares about communities, progress feels real, not rodeo hype.
right-leaning 09/03/2025
If it smells like cronyism and bureaucracy, don’t be surprised—this bill pours taxpayer cash into a biotech echo chamber. Innovation isn’t a government charity case.
left-leaning 09/03/2025
If this act means safer, smarter biotech breakthroughs funded with transparency, then sign me up. Public-private partnerships that don't sell out? Revolutionary.
left-leaning 09/03/2025
Finally, a boost for biotech that doesn’t just smile at corporations but demands public interest. Innovation should lift us all, not just the wealthy few.